Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Company Profile for Crospon

Posted on: 19 May 17

Crospon is an endoscopic diagnostics company that is changing the face of esophageal function testing with its Endoflip® imaging system and Esoflip® balloon catheter technologies. The minimally invasive medical devices transform the patient experience when it comes to swallow testing and deliver a whole new diagnostic tool set into the hands of gastroenterology professionals.

Continuing Crospon’s commitment to deliver information into the hands of gastroenterologists, the next generation Endoflip® 2.0 displays real-time esophageal contractility patterns on a touch screen. The patented technology enables gastroenterologists, for the first time, to investigate for conditions such as achalasia, GEJ outflow obstruction and other major or minor disorders of peristalsis during endoscopy.

Established in 2006 by chairman and chief executive John O’Dea and with offices in the US and Ireland, Crospon’s experienced team designs and manufactures medical devices that allow clinicians to assess the real-time effects of their interventions during endoscopic and laparoscopic procedures.



Headquarters Address:

Galway Business Park
GALWAY 00000

Main Telephone:




Type of Organization:



Medical Devices

Key Executives:

CEO: John O'Dea

CFO: Caroline Sherlock

CTO: Adrian McHugh


Customer Service


John O'Dea




View source version on

Business Wire

Last updated on: 19/05/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.